Yasuhiro Sato

Suggest Changes
Learn More
The combination of docetaxel, cisplatin, and S-1 (DCS) chemotherapy is expected to be a promising regimen for advanced gastric cancer. This study was performed to evaluate the efficacy and safety of(More)
The original version of this article unfortunately contained an error in Table 2. Table 2 should be shown as follows. In addition, in the ‘‘Results’’ section, in the second paragraph under the(More)